Appendix 1. Risk estimates for CIN3+ based on colposcopy impression and cytology result. ES, estimated risk of CIN3+; I-squared only calculated when number of studies is greater than 3.

(1)

Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, et al Risk of cervical intraepithelial neoplasia 2 or worse by cytology, human papillomavirus 16/18, and colposcopy impression: a systematic review and meta-analysis. Obstet Gynecol 2018; 132. The authors provided this information as a supplement to their article.

Appendix 1. Risk estimates for CIN3+ based on colposcopy impression and cytology result. ES, estimated risk

of CIN3+; I-squared only calculated when number of studies is greater than 3.

(2)

Appendix 2. Risk estimates for CIN3+ based on colposcopy impression and HPV16/18 status. ES, estimated

risk of CIN3+; I-squared only calculated when number of studies is greater than 3.

(3)

Appendix 3. Risk estimates for CIN3+ based on colposcopy impression, cytology result, and HPV16/18

status. ES, estimated risk of CIN3+; I-squared only calculated when number of studies is greater than 3.

(4)

(5)

Appendix 4. Risk estimates for CIN2+ based on colposcopy impression and cytology result. ES, estimated risk

of CIN2+; I-squared only calculated when number of studies is greater than 3.

(6)

Appendix 5. Risk estimates for CIN2+ based on colposcopy impression and HPV16/18 status. ES, estimated

risk of CIN2+; I-squared only calculated when number of studies is greater than 3.

(7)

Appendix 6. Risk estimates for CIN2+ based on colposcopy impression, cytology result, and HPV16/18

status. ES, estimated risk of CIN2+; I-squared only calculated when number of studies is greater than 3.

(8)